首页> 外文期刊>Southern Med Review >Patterns of infections and antimicrobial drugs’ prescribing among pregnant women in Saudi Arabia: a cross sectional study
【24h】

Patterns of infections and antimicrobial drugs’ prescribing among pregnant women in Saudi Arabia: a cross sectional study

机译:沙特阿拉伯孕妇在孕妇中规定的感染和抗菌药物模式:横断面研究

获取原文
获取外文期刊封面目录资料

摘要

Antimicrobial agents are among the most commonly prescribed drugs in pregnancy due to the increased susceptibility to infections during pregnancy. Antimicrobials can contribute to different maternal complications. Therefore, it is important to study their patterns in prescription and utilization. The data regarding this issue is scarce in Saudi Arabia. Therefore, the aim of this study is to generate data on the antimicrobial agents that are most commonly prescribed during pregnancy as well as their indications and safety. This is a retrospective study focusing on pregnant women with a known antimicrobial use at Johns Hopkins Aramco Healthcare (JHAH). The sample included 344 pregnant women with a total of 688 antimicrobial agents prescribed. Data was collected on the proportion of pregnant women who received antimicrobial agents and on the drug safety during pregnancy using the risk categorization system of the U.S. Food and Drug Administration (FDA). The results showed that urinary tract infections (UTIs) were the most reported (59%) infectious diseases. Around 48% of pregnant women received antimicrobial medications at some point during pregnancy. The top two antimicrobial agents based on prescription frequency were B-lactams (44.6%) and azole anti-fungals (30%). The prescribed drugs in the study were found to be from classes B, C and D under the FDA risk classification system. The study revealed a high proportion of antimicrobials prescribed during pregnancy that might pose risks to mothers and their fetuses. Future multicenter studies are warranted to evaluate the rational prescription of antimicrobial medications during pregnancy.
机译:由于在怀孕期间感染的易感性增加,抗菌剂是怀孕中最常见的药物之一。抗微生物可以有助于不同的母体并发症。因此,重要的是在处方和利用方面研究它们的模式。关于这个问题的数据在沙特阿拉伯稀缺。因此,本研究的目的是生成关于在怀孕期间最常见的抗微生物剂的数据以及它们的指示和安全性。这是一项重点研究,重点是在约翰霍普斯阿拉莫斯医疗保健(JHAH)的孕妇患有已知的抗菌用途。该样品包括344名孕妇,共有688名抗菌药剂。采用美国食品和药物管理局(FDA)的风险分类系统,收集了接受抗菌药物的孕妇比例和妊娠的药物安全性的数据。结果表明,尿路感染(UTI)是最多报道(59%)的传染病。在怀孕期间的某些点,孕妇的约48%受到抗菌药物。基于处方频率的前两种抗菌剂是B-内酰胺(44.6%)和唑抗真菌(30%)。在FDA风险分类系统下发现该研究中的规定药物来自课程B,C和D.该研究揭示了在怀孕期间规定的高比例的抗菌药物,这可能会对母亲及其胎儿构成风险。未来的多中心研究是有必要在怀孕期间评估抗菌药物的合理处方。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号